Error: Could not add to watchlist. X

Prosensa Holding NV

+ Watchlist
RNA:US
Acquired
RNA:US was acquired by BMRN:US
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (EUR) (TTM)
-1.25
Market Cap (USD)
-
Shares Outstanding (m)
36.141
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Prosensa Holding NV is a biotechnology company engaged in the discovery and development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The Company's primary focus is on neuromuscular and neurodegenerative disorders, including Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease.
ADDRESS
JH Oortweg 21
Leiden, NL-2333 CH
Netherlands
PHONE
31-71-33-22-100
  • Berndt A E Modig
    CFO/Member-Mgmt Board
  • Luc Dochez
    Senior VP:Bus Dev/Chief Bus Ofcr
  • Giles V Campion
    Senior VP:R&D/Chief Medical Ofcr
Show More